You are in: eMedicine Specialties > Dermatology > DISEASES OF THE ORAL MUCOSA Hairy TongueArticle Last Updated: Dec 15, 2006AUTHOR AND EDITOR INFORMATIONAuthor: Denis Lynch, DDS, PhD, Associate Dean for Academic Affairs, School of Dentistry, Office of the Dean, Marquette University Denis Lynch is a member of the following medical societies: American Academy of Oral and Maxillofacial Pathology, American Dental Association, International Association for Dental Research, and Sigma Xi Editors: Bernice R Krafchik, MBChB, FRCPC, Professor Emeritus, Department of Pediatrics, Section of Dermatology, University of Toronto; David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic; Drore Eisen, MD, DDS, Consulting Staff, Department of Dermatology, Dermatology Research Associates of Cincinnati; Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University; William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System Author and Editor Disclosure Synonyms and related keywords: lingua nigra, lingua villosa, lingua villosa nigra, black hairy tongue, defective desquamation of the filiform papillae, poor oral hygiene, therapeutic radiation, glossopyrosis, burning tongue, Candida albicans, halitosis, hypertrophy of filiform papillae, tobacco use, coffee drinking, tea drinking INTRODUCTIONBackgroundHairy tongue (lingua villosa) is a commonly observed condition of defective desquamation of the filiform papillae that results from a variety of precipitating factors. The condition is most frequently referred to as black hairy tongue (lingua villosa nigra); however, hairy tongue may also appear brown, white, green, pink, or any of a variety of hues depending on the specific etiology and secondary factors (eg, use of colored mouthwashes, breath mints, candies). PathophysiologyPrecipitating factors for hairy tongue include poor oral hygiene, the use of medications (especially broad-spectrum antibiotics), and therapeutic radiation of the head and the neck. All cases of hairy tongue are characterized by a hypertrophy and elongation of filiform papillae, with a lack of normal desquamation. Normal filiform papillae are approximately 1 mm in length, whereas filiform papillae in hairy tongue have been measured at more than 15 mm in length. FrequencyUnited StatesThe prevalence of hairy tongue varies widely, from 8.3% in children and young adults to 57% in persons who are addicted to drugs and incarcerated. Hairy tongue has been reported with greater frequency in males, those who use tobacco, those who heavily drink coffee and tea, patients infected with HIV, and those who are HIV negative and use intravenous drugs. Mortality/MorbidityHairy tongue is rarely symptomatic, although overgrowth of Candida albicans may result in glossopyrosis (burning tongue). Patients frequently complain of a tickling sensation in the soft palate and the oral pharynx during swallowing. In more severe cases, patients may actually complain of a gagging sensation. Retention of oral debris between the elongated papillae may result in halitosis. RaceNo racial predilection is associated with hairy tongue. SexAlthough hairy tongue is reported more often in males, it is not uncommon in females, especially those who drink coffee or tea and/or those who use tobacco. AgeThe incidence and the prevalence of hairy tongue increases with age, possibly because a higher percentage of the population engage in activities (eg, using tobacco, drinking coffee or tea) that predispose to the condition. CLINICALHistoryBecause hairy tongue is usually asymptomatic, the history is often irrelevant.
Physical
Causes
DIFFERENTIALSCandidiasis, Mucosal Leukoplakia, Oral Lichen Planus
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Name | Clotrimazole (Mycelex) |
|---|---|
| Description | Broad-spectrum antifungal agent that inhibits yeast growth by altering cell membrane permeability, causing death of fungal cells. Reevaluate diagnosis if no clinical improvement after 2 wk. Effective in the treatment of oral candidiasis; however, it has some drawbacks. Has high sugar content and peppermint flavor to mask the bitter taste of clotrimazole. High sugar content makes it relatively contraindicated in persons with diabetes. Dosing regimen occasionally results in poor patient compliance; nevertheless, it is an effective medication to treat oral candidiasis and is especially efficacious in treating candidal infections on the dorsal surface of the tongue. |
| Adult Dose | 10 mg troche dissolved in mouth 5 times/d for 2 wk; do not eat or drink for 30 min after treatment |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | B - Usually safe but benefits must outweigh the risks. |
| Precautions | Not for treatment of systemic fungal infections; avoid contact with the eyes; discontinue use and institute appropriate therapy if irritation or sensitivity develops; caution in persons with diabetes because of high sugar content of troche; dental carries may occur in individuals who are prone; patients with xerostomia may not be able to dissolve troches |
| Drug Name | Nystatin (Mycostatin) |
|---|---|
| Description | Fungicidal and fungistatic antibiotic obtained from Streptomyces noursei. Effective against various yeasts and yeastlike fungi. Changes permeability of fungal cell membrane after binding to cell membrane sterols, causing cellular contents to leak. Treatment should continue until 48 h after disappearance of symptoms. Drug is not significantly absorbed from GI tract. Effective to treat oral candidiasis; however, it has some drawbacks. Has high sugar content and licorice flavor to mask the bitter taste of nystatin. High sugar content makes it relatively contraindicated in persons with diabetes. Some patients have an aversion to licorice flavoring. Dosing regimen occasionally results in poor patient compliance; nevertheless, it is an effective medication to treat oral candidiasis and is especially efficacious in treating candidal infections on the dorsal surface of the tongue. |
| Adult Dose | 200,000-400,000 U pastilles dissolved in mouth q4h for 2 wk; do not eat or drink for 30 min after treatment |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Do not use to treat systemic mycoses; caution in persons with diabetes because of high sugar content of pastille; dental carries may occur in individuals who are prone; patients with xerostomia may not be able to dissolve troches |
| Drug Name | Ketoconazole (Nizoral) |
|---|---|
| Description | Fungistatic activity. Imidazole broad-spectrum antifungal agent. Inhibits synthesis of ergosterol, causing cellular components to leak and resulting in fungal cell death. Effective in treating oral candidiasis, especially when patients do not comply with multidosing topical therapies or are unable to tolerate sugar-containing troches and pastilles. Take with food. |
| Adult Dose | 200 mg PO qd for 2 wk |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | Isoniazid may decrease bioavailability; coadministration decreases effects of either rifampin or ketoconazole; may increase effect of anticoagulants; may increase toxicity of corticosteroids and cyclosporine (cyclosporine dosage can be adjusted); may decrease theophylline levels |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Hepatotoxicity may occur; may reversibly decrease corticosteroid serum levels (adverse effects avoided with dose of 200-400 mg/d); administer antacid, anticholinergics, or H2-blockers at least 2 h after ketoconazole |
| Drug Name | Fluconazole (Diflucan) |
|---|---|
| Description | Fungistatic activity. Synthetic oral antifungal (broad-spectrum bistriazole) that selectively inhibits fungal cytochrome P-450 and sterol C-14 alpha-demethylation, which prevents conversion of lanosterol to ergosterol, thereby disrupting cellular membranes. Effective in treating oral candidiasis, especially when patients do not comply with multidosing topical therapies or are unable to tolerate sugar-containing troches and pastilles. Normally prescribed in situations where other topical or systemic medications have not been successful. Especially useful in treating oral candidiasis in patients who are immunosuppressed. |
| Adult Dose | 150 mg PO once or 400 mg qd, depending on severity of infection |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity |
| Interactions | Levels may increase with hydrochlorothiazide; levels may decrease with chronic coadministration of rifampin; coadministration may decrease phenytoin clearance; may increase concentrations of theophylline, tolbutamide, glyburide, and glipizide; effects of anticoagulants may increase with coadministration; increases in cyclosporine concentrations may occur when administered concurrently |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | Adjust dose for renal insufficiency; monitor closely if rash develops and discontinue drug if lesions progress; may cause clinical hepatitis, cholestasis, and fulminant hepatic failure (including death) with underlying medical conditions (eg, AIDS, malignancy) or while taking multiple concomitant medications; not recommended in breastfeeding |
| Media file 1: Brown hairy tongue in a middle-aged woman who drinks coffee. Note how the condition is limited to the mid-dorsal part of the tongue, becoming more prominent toward the posterior part. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 2: Brown hairy tongue in a middle-aged man who smokes cigarettes. The condition is limited to the posterior two thirds of the dorsal surface of the tongue. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 3: Close-up view of the patient in Image 2. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 4: This patient is a middle-aged woman who drank coffee and smoked cigarettes for many years. Her chief complaint was a tickling sensation in the oral pharynx during swallowing. The slight greenish cast to her tongue was due to the use of a mouthwash immediately prior to her appointment. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 5: This male geriatric patient had smoked a pipe for many years. He was unaware of the presence of his hairy tongue until it was brought to his attention during a routine dental examination. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 6: The same patient as in Image 5 one month following his initial examination. While he has not decreased his pipe smoking, he has gently brushed the dorsal surface of his tongue when he brushes his teeth during the intervening 4 weeks. The hairy tongue has completely resolved. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 7: Middle-aged woman with a hairy tongue that is brown. | |
![]() | View Full Size Image | Media type: Photo |
Article Last Updated: Dec 15, 2006